Rocket One (RKTO) Long-Term Investments (2021 - 2026)
Rocket One's (RKTO) quarterly Long-Term Investments came in at $36819.0 in Q2 2026, little changed year-over-year from $36819.0 in Q2 2025, and little changed quarter-over-quarter from $36819.0 in Q1 2026.
Analysis
Rocket One (RKTO) Long-Term Investments (2021 - 2026) Analysis & Trends
Rocket One has disclosed Long-Term Investments across 6 years of filings, most recently posting $36819.0 for Q2 2026.
- In Q2 2026, Long-Term Investments changed 0.0% year-over-year to $36819.0; the TTM figure through Jun 2026 stood at $36819.0 (changed 0.0% YoY), while the FY2025 annual figure was $36819.0, changed 0.0% from the prior year.
- Long-Term Investments came in at $36819.0 for Q2 2026 at Rocket One, roughly flat from $36819.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $387400.0 in Q2 2022 to a low of $33000.0 in Q4 2022.
- Average Long-Term Investments over 5 years is $77458.2, with a median of $36819.0 recorded in 2024.
- Year-over-year, Long-Term Investments plunged 91.95% in 2022 and rose 13.33% in 2023.
- Over 5 years, Long-Term Investments stood at $33000.0 in 2022, then grew by 13.33% to $37400.0 in 2023, then dropped by 1.55% to $36819.0 in 2024, then changed by 0.0% to $36819.0 in 2025, then changed by 0.0% to $36819.0 in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $36819.0 in Q2 2026, $36819.0 in Q1 2026, and $36819.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 5.79 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 9.83 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | -4.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 1.77 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 36,819.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,819.00 |
| Mar 31, 2026 | 36,819.00 |
| Dec 31, 2025 | 36,819.00 |
| Sep 30, 2025 | 36,819.00 |
| Jun 30, 2025 | 36,819.00 |
| Mar 31, 2025 | 36,819.00 |
| Dec 31, 2024 | 36,819.00 |
| Sep 30, 2024 | 36,819.00 |
| Jun 30, 2024 | 36,819.00 |
| Mar 31, 2024 | 36,819.00 |
| Dec 31, 2023 | 37,400.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 37,400.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Sep 30, 2022 | 387,400.00 |
| Jun 30, 2022 | 387,400.00 |
| Dec 31, 2021 | 410,000.00 |